<DOC>
	<DOCNO>NCT00139854</DOCNO>
	<brief_summary>This multicenter , open-label , randomize crossover trial compare two treatment , Alprazolam ODT versus conventional alprazolam tablet , subject already take conventional immediate-release alprazolam tablet anxiety . The trial include five study visit ( four period 7 3 -day duration ) : Screening ( Visit 1 ) , Treatment Period 1 ( Visit 2 ) , Treatment Period 2 ( Visit 3 ) , Final Visit ( Visit 4 ) , Follow-up ( Visit 5 [ telephone visit ] ) . At Visit 1 , follow screening , eligible subject continue take conventional alprazolam prescribe physician . At Visit 2 , eligible subject randomize approximately equal number one two treatment sequence : Alprazolam ODT/ conventional alprazolam conventional alprazolam/ Alprazolam ODT . Subjects continue take alprazolam accordance treatment sequence assign , dose regimen prescribe alprazolam . At Visit 3 , subject cross alternate treatment Visit 4 . At Visit 4 , subject complete Subject Preference Questionnaire , physical examination clinical laboratory test perform . At end Visit 4 , subject resume take conventional alprazolam . The site make follow-up telephone call 7 - 3 day Visit 4 ass subject 's health status .</brief_summary>
	<brief_title>A Multicenter , Open-Label , Randomized Crossover Trial Assess Subject Preference Alprazolam Orally Disintegrating Tablets Compared Conventional Alprazolam Tablets Subjects With Anxiety</brief_title>
	<detailed_description>See approve Package Insert Adverse Event information .</detailed_description>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Alprazolam</mesh_term>
	<criteria>Currently treat conventional alprazolam Dose great 10 mg</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>